TUCSON, Ariz., and AUSTIN, Texas – October 18, 2017 –Critical Path Institute (C-Path) and The Clinical Data Interchange Standards Consortium (CDISC) announce the open availability of a Duchenne Muscular Dystrophy Therapeutic Area User Guide (TAUG-DMD v1.0), which describes the most common clinical concepts relevant to Duchenne studies using the CDISC standard format. This format allows datasets from different sources to be compared or combined for data collection, sharing, and analyses.Continue reading
Author Archive: AZBio
Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer
Use of arsenic trioxide could extend survival of some glioblastoma patients by three to four times historic medianContinue reading
International Society for Mechanical Circulatory Support (ISMCS) Begins This Week in Tucson with the Goal of Helping Heart Failure Patients Live Longer, Better Lives
Marvin J. Slepian, MD, Arizona Bioscience Pioneer Award for Lifetime Achievement recipient to host ISMCS 2017 in Tucson
This Week, October 16-18, Dr. Slepian Brings the International Society for Mechanical Circulatory Support (ISMCS) to Tucson with the Goal of Helping Heart Failure Patients Live Longer, Better LivesContinue reading
Successful treatment for advanced stage testicular cancer in down syndrome patients
Research by Jue Wang, MD, at the University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center on “Delay in Diagnosis of Testicular Cancer in a Patient with Down Syndrome” was published in the October issue of Journal of Cancer and Therapeutic Science.
Patents for Humanity Awards Now Open for Applications
Patents for Humanity, the USPTO’s top honor for patent owners and licensees who use game-changing technology to meet humanitarian needs, is now accepting applications for the 2017 – 2018 cycle. Anyone who owns or licenses a U.S. patent or patent application is eligible. Winners receive an acceleration certificate to expedite proceedings at the USPTO, as well as public recognition of their work.Continue reading
TGen receives $2.5 million SU2C grant for new pancreatic cancer clinical trial
Investigation with Salk and Mayo Clinic headed by TGen’s Dr. Von Hoff is one of 10 ‘SU2C Catalyst’ studies using powerful new approachesContinue reading
Video Gallery Celebrating our 2017 AZBio Awards Winners
On October 11, 2017, we celebrated the AZBio Awards. We invite you to watch the videos to learn more about our AZBio Awards Honorees. Continue reading
TGen sequencing test enables precise identification of drug-resistant TB
UCSF and TGen researchers advance SMOR testing, with an eye on precision medicine for tuberculosisContinue reading